Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31.3M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
27.6M
-
Shares change
-
+360K
-
Total reported value, excl. options
-
$2.02B
-
Value change
-
+$30M
-
Put/Call ratio
-
0.7
-
Number of buys
-
103
-
Number of sells
-
-78
-
Price
-
$73.20
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q2 2018
212 filings reported holding CNMD - CONMED Corp - Common Stock as of Q2 2018.
CONMED Corp - Common Stock (CNMD) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.6M shares
of 31.3M outstanding shares and own 88.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.76M shares), VANGUARD GROUP INC (2.51M shares), DIMENSIONAL FUND ADVISORS LP (1.88M shares), SCOPIA CAPITAL MANAGEMENT LP (1.72M shares), Capital Research Global Investors (1.6M shares), Champlain Investment Partners, LLC (1.34M shares), VICTORY CAPITAL MANAGEMENT INC (1.21M shares), STATE STREET CORP (958K shares), GOLDMAN SACHS GROUP INC (795K shares), and MACQUARIE GROUP LTD (779K shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.